DYN
Dyne Therapeutics Inc
16.00$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Dyne Therapeutics Inc (DYN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -403 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 341 | 319 | 135 | 423 | -20 | -44 | 175 | -62 | 94 | 676 | 585 | -4.2 | -12 | -47 | -120 | -154 | -188 | -292 | -403 | |
| 333 | 376 | 359 | 408 | 346 | 26 | 467 | 292 | 614 | 766 | 867 | 0.0 | 0.3 | 0.7 | 1.1 | 1.7 | 1.7 | -1.9 | 2.0 | |
| -522 | – | – | – | – | – | 15 | 19 | 28 | 31 | 44 | 0.0 | 0.0 | 6.6 | 18 | 15 | 20 | 46 | 46 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0 | 1.3 | 7.1 | 19 | 18 | – | – | – | |
| 522 | 437 | -910 | 488 | -166 | 183 | 268 | 1,029 | -860 | 938 | -1,596 | 0.6 | 1.4 | 5.1 | 9.3 | -5.4 | 26 | -19 | -3.4 | |
| 0.0 | 0.0 | 0.0 | 333 | 242 | 0.0 | 98 | 0.0 | 275 | 326 | 224 | 0.1 | 1.6 | 1.2 | 3.6 | 3.1 | 0.7 | 2.4 | 1.9 | |
| -817 | -102 | 251 | -534 | -254 | 348 | 474 | -5,148 | -1,194 | -2,147 | -2,759 | -0.1 | -1.6 | -46 | -138 | 87 | 83 | -204 | -29 | |
| – | – | – | – | – | – | – | – | 23 | 22 | 22 | – | – | – | – | – | – | – | – | |
| – | – | – | -291 | -396 | -348 | -843 | -1,870 | -250 | – | – | 7.4 | 20 | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -0.1 | -0.1 | -0.1 | 0.0 | – | 0.0 | 0.0 | 148 | |
| 433 | 148 | -608 | -69 | 379 | -328 | -154 | 5,210 | -265 | 2,742 | -1,299 | 12 | 20 | 381 | 158 | 37 | 54 | 810 | 890 | |
| -43 | 365 | -222 | -180 | 105 | -107 | 495 | -5,148 | -1,365 | 1,271 | -3,473 | 12 | 6.5 | 289 | -100 | -29 | -51 | 313 | 458 | |
| 341 | 319 | 135 | 90 | -262 | -44 | 77 | -62 | -181 | 350 | 361 | -4.3 | -13 | -48 | -123 | -157 | -189 | -295 | -405 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.